References
- Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW. Cancer genome landscapes. Science 2013;339:1546-1558. https://doi.org/10.1126/science.1235122
- Kan Z, Jaiswal BS, Stinson J, Janakiraman V, Bhatt D, Stern HM, et al. Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 2010;466:869-873. https://doi.org/10.1038/nature09208
- Schweiger MR, Barmeyer C, Timmermann B. Genomics and epigenomics: new promises of personalized medicine for cancer patients. Brief Funct Genomics 2013;12:411-421. https://doi.org/10.1093/bfgp/elt024
- Martincorena I, Campbell PJ. Somatic mutation in cancer and normal cells. Science 2015;349:1483-1489. https://doi.org/10.1126/science.aab4082
- Suva ML, Riggi N, Bernstein BE. Epigenetic reprogramming in cancer. Science 2013;339:1567-1570. https://doi.org/10.1126/science.1230184
- Baylin SB. DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol 2005;2 Suppl 1:S4-S11. https://doi.org/10.1038/ncponc0354
- Kim MS, Lee J, Sidransky D. DNA methylation markers in colorectal cancer. Cancer Metastasis Rev 2010;29:181-206. https://doi.org/10.1007/s10555-010-9207-6
- Breuer K, Foroushani AK, Laird MR, Chen C, Sribnaia A, Lo R, et al. InnateDB: systems biology of innate immunity and beyond: recent updates and continuing curation. Nucleic Acids Res 2013;41:D1228-D1233. https://doi.org/10.1093/nar/gks1147
- Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003;349:2042-2054. https://doi.org/10.1056/NEJMra023075
- Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology 2010;138:2073-2087.e3. https://doi.org/10.1053/j.gastro.2009.12.064
- Horsthemke B. Epimutations in human disease. Curr Top Microbiol Immunol 2006;310:45-59.
- Colussi D, Brandi G, Bazzoli F, Ricciardiello L. Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention. Int J Mol Sci 2013;14:16365-16385. https://doi.org/10.3390/ijms140816365
- Yuan W, Lopez Bernal A. Cyclic AMP signalling pathways in the regulation of uterine relaxation. BMC Pregnancy Childbirth 2007;7 Suppl 1:S10. https://doi.org/10.1186/1471-2393-7-S1-S10
- Ritter SL, Hall RA. Fine-tuning of GPCR activity by receptor-interacting proteins. Nat Rev Mol Cell Biol 2009;10:819-830. https://doi.org/10.1038/nrm2803
- Agid Y, Buzsaki G, Diamond DM, Frackowiak R, Giedd J, Girault JA, et al. How can drug discovery for psychiatric disorders be improved? Nat Rev Drug Discov 2007;6:189-201. https://doi.org/10.1038/nrd2217
- Dufresne M, Seva C, Fourmy D. Cholecystokinin and gastrin receptors. Physiol Rev 2006;86:805-847. https://doi.org/10.1152/physrev.00014.2005
- Goodchild RE, Grundmann K, Pisani A. New genetic insights highlight 'old' ideas on motor dysfunction in dystonia. Trends Neurosci 2013;36:717-725. https://doi.org/10.1016/j.tins.2013.09.003
- Ligeti E, Welti S, Scheffzek K. Inhibition and termination of physiological responses by GTPase activating proteins. Physiol Rev 2012;92:237-272. https://doi.org/10.1152/physrev.00045.2010
- Dorsam RT, Gutkind JS. G-protein-coupled receptors and cancer. Nat Rev Cancer 2007;7:79-94. https://doi.org/10.1038/nrc2069
- Airaksinen MS, Saarma M. The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci 2002;3:383-394. https://doi.org/10.1038/nrn812
- Hitchins MP. Constitutional epimutation as a mechanism for cancer causality and heritability? Nat Rev Cancer 2015;15:625-634. https://doi.org/10.1038/nrc4001